This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
As a growing number of firms line up to challenge Cepheid’s and Becton Dickinson’s molecular tests for hospital-acquired infections, Accelr8 is developing a single-cell test system that could potentially supply a physician with more critical information within a few hours.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.